FAQ

David R. Andes

Suggest Changes
José Luis López-Ribot145
Mahmoud A. Ghannoum123
Michael A. Pfaller106
John H. Rex92
George Louis Drusano92
72Jeniel E. Nett
64Jose L. Lopez-Ribot
64Alexander J. Lepak
64Clarissa J. Nobile
62Michael A. Pfaller

Filter Results:

  • Full text PDF available (123)

Publication Year

1996
2018
  • This year (20)
  • Last 5 years (93)
  • Last 10 years (136)

Publication Type

Co-author

Journals and Conferences

Method

Learn More
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
BACKGROUND Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among organ transplant recipients. Multicenter prospective surveillance data to determine disease burden and… (More)
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET)…
BACKGROUND The incidence and epidemiology of invasive fungal infections (IFIs), a leading cause of death among hematopoeitic stem cell transplant (HSCT) recipients, are derived mainly from… (More)
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.
BACKGROUND Invasive candidiasis (IC) is an important healthcare-related infection, with increasing incidence and a crude mortality exceeding 50%. Numerous treatment options are available yet… (More)
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.
BACKGROUND Both the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) have MIC clinical breakpoints (CBPs) for fluconazole… (More)